ArticleStatistics in biopharmaceutical research2018

An adaptive dose-finding design based on both safety and immunologic responses in cancer clinical trials.

Cody Chiuzan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.